TY  - GEN
AU  - Beaulieu,Marie-Eve
AU  - Jauset,Toni
AU  - Massó-Vallés,Daniel
AU  - Martínez-Martín,Sandra
AU  - Rahl,Peter
AU  - Maltais,Loïka
AU  - Zacarias-Fluck,Mariano F
AU  - Casacuberta-Serra,Sílvia
AU  - Serrano Del Pozo,Erika
AU  - Fiore,Christopher
AU  - Foradada,Laia
AU  - Cano,Virginia Castillo
AU  - Sánchez-Hervás,Meritxell
AU  - Guenther,Matthew
AU  - Romero Sanz,Eduardo
AU  - Oteo,Marta
AU  - Tremblay,Cynthia
AU  - Martín,Génesis
AU  - Letourneau,Danny
AU  - Montagne,Martin
AU  - Morcillo Alonso,Miguel Ángel
AU  - Whitfield,Jonathan R
AU  - Lavigne,Pierre
AU  - Soucek,Laura
TI  - Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy
SN  - 1946-6242
PY  - 2020///0417
KW  - Adenocarcinoma of Lung
KW  - drug therapy
KW  - Animals
KW  - Basic-Leucine Zipper Transcription Factors
KW  - metabolism
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Cell Line, Tumor
KW  - Cell-Penetrating Peptides
KW  - pharmacokinetics
KW  - DNA
KW  - Disease Models, Animal
KW  - E-Box Elements
KW  - genetics
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Mice, Inbred C57BL
KW  - Peptide Fragments
KW  - administration & dosage
KW  - Promoter Regions, Genetic
KW  - Protein Binding
KW  - drug effects
KW  - Protein Multimerization
KW  - Proto-Oncogene Proteins c-myc
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1126/scitranslmed.aar5012
ER  -